Patient Testimonials

ENT Research at the California Sinus Centers

 

Otolaryngology, ENT & Sinus News Provided by the California Sinus Centers

Natural History of Cervical Paragangliomas: Outcomes of Observation of 43 Patients [Original Article]

March 19, 2012, 12:00 pm by Archives of Otolaryngology Head & Neck Surgery

Objective  To evaluate the outcomes, growth rate, and symptoms of nonoperated cervical paragangliomas. Design  Retrospective review of clinical and radiologic records and images. Setting  Tertiary academic medical center. Patients  We studied all patients presenting with cervical paragangliomas between 1993 and 2010 who were observed rather than operated on. Main Outcome Measures  Growth of tumors and need for surgical removal. Results  Forty-three patients with 47 tumors were identified. Mean patient age was 56 years (age range, 17-86 years). Thirty patients were asymptomatic (70%) (22 diagnosed by imaging for other reasons and 8 for workup of a neck mass), and only 5 presented with cranial nerve abnormalities (12%). No patients presented with lymphadenopathy, rapid growth, or pain. Reasons for observation were patient preference (n = 15; 35%), advanced age of patient (n = 12; 28%), and preexisting contralateral cranial nerve deficits (n = 11; 26%). Twenty-eight of the 47 tumors were suspected carotid body tumors based on imaging (60%), and 19 were suspected vagal tumors (40%). The mean greatest dimension at presentation was 2.6 cm (range, 1-7.2 cm). During a mean follow-up of 5 years (range, 1-17 years), 19 tumors remained stable in size (42%); 17 grew (38%); and 9 regressed (20%). Of the 17 tumors that grew, the mean growth was 0.2 cm/y. Conclusions  Observation of cervical paragangliomas is an option in selected patients who do not present with worrisome symptoms. The natural history of paragangliomas in these patients is typically little to no growth over time. Regular follow-up is important to ensure minimal change and stable symptoms.

Read the full article


More from Archives of Otolaryngology Head & Neck Surgery

Incidence of Pediatric Acute Mastoiditis: 1997-2006 [Original Article]
Archives of Otolaryngology Head & Neck Surgery: April 16, 2012, 12:00 pm
Objectives  To evaluate the incidence of acute mastoiditis in children in the United States over the years 1997 through 2006 and to explore possible explanations for the conflicting conclusions of recent studies

Radiotherapy in Parotid Acinic Cell Carcinoma: Does It Have an Impact on Survival? [Original Article]
Archives of Otolaryngology Head & Neck Surgery: April 16, 2012, 12:00 pm
Objective  Acinic (or acinar) cell carcinoma (ACC) represents approximately 10% of salivary gland malignant tumors and most commonly occurs in the parotid gland. It carries a propensity for locoregional and distant metastasis.

Koi frenzy [About the Cover]
Archives of Otolaryngology Head & Neck Surgery: April 1, 2012, 12:00 pm


About This Journal [About This Journal]
Archives of Otolaryngology Head & Neck Surgery: April 1, 2012, 12:00 pm


Complications of Adenotonsillectomy in Patients Younger Than 3 Years [Original Article]
Archives of Otolaryngology Head & Neck Surgery: April 1, 2012, 12:00 pm
Objective  To evaluate the complication rate for adenotonsillectomy in children younger than 3 years, without a diagnosis of severe obstructive sleep apnea, to assess the necessity for postoperative inpatient admission. Design  Retrospective medical

 

NOTICE: The CSC web site "Otolaryngology ENT Industry News" has data and links presented by way of the above mentioned RSS news feeds. We offer this industry news for your convenience and education. CSC does not review the information provided in this section. CSC does not assume any endorsement or present these third-party feeds and links as CSC belief or in conjunction with CSC whatsoever. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by the California Sinus Centers. For more information, please see our disclaimer.